Sign up
or
Register for free
BioNation
RSS
Companies
Jobs
Drugs
News
Home
News Center
Directory
Articles
Recent
News Center
Companies
Drugs
Marketed Drugs
Investigational Drugs
Jobs
Pharma & Biotech
Chemistry
Medtech
Healthcare
Food & Beverage
Finance
Shop
Market Research
Corporate Solutions
BioNation
Login
Email
Password
I've forgotten my password!
Create an account here!
Therapeutic Areas
Nervous System
Gastroenterology
Infectious Diseases
Oncology
Immunology
Cardio-Vascular
Endocrinology
Dermatology
Ophtalmology
Genitourinary System
Pain and Anesthesia
Respiratory System
Competencies
Biotechnology
Drug Delivery
Gene and Cell Therapy
Genomics
Technology Platforms
Vaccines
Tissue Engineering
Proteomics
Services
CRO
CMO
Diagnostic Tools
Imagery
Chemistry
Devices
Device
Biomaterials
Lab and Hospital Equipment
Genitourinary System
Genitourinary
System Business News
stromedix, inc. receives fda orphan drug designation for stx-100 for the treatment of idiopathic pul
...
Aug 31 2010
fda grants urigen pharmaceuticals, inc.'s urg101 meeting
...
Aug 18 2010
palatin technologies (ptn) announces positive safety results in subcutaneous bremelanotide trial in
...
Aug 17 2010
glenmark generics receives approval from usfda for trospium tablets
...
Aug 16 2010
urigen pharmaceuticals, inc. announces fda follow up
...
Aug 11 2010
nymox pharmaceutical (nymx) reports safety monitoring committee findings for pivotal phase 3 nx-1207
...
Jul 28 2010
stellar pharmaceuticals inc. (slx.v) issued uracyst(r) patents in the united states and china
...
Jul 28 2010
Genitourinary System
Jobs
Find an open position today!
Profile
Puricase: A New Cure for Gout?
Puricase might help disolve monosodium urate crystal deposits in and around joints.
by Ronald Maldonado Rodriguez, PhD MSc , 24/04/2008
Profile
News from the Genitourinary Chemistry Front
by Tristan Estoppey , 10/04/2008
Genitourinary
System Headlines
Stromedix, Inc. Receives FDA Orphan Drug Designation for STX-100 for the Treatment of Idiopathic Pulmonary Fibrosis
Tue, 12:00 (GMT+1)
FDA Grants Urigen Pharmaceuticals, Inc.'s URG101 Meeting
Wed, 12:00 (GMT+1)
Palatin Technologies (PTN) Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in ...
Glenmark Generics receives approval from USFDA for Trospium tablets ...
Urigen Pharmaceuticals, Inc. Announces FDA Follow Up ...
Get the RSS feed you need!
Genitourinary
System Partnerships